conditionStudied

URI: https://gptkb.org/prop/conditionStudied

93 triples

GPTKB property

diseaseStudied • studiedCondition

Subject	Object
gptkb:Max_Essex	retroviral diseases
gptkb:Heart_to_Hub	mitral regurgitation
gptkb:CheckMate_227	gptkb:non-small_cell_lung_cancer
gptkb:NCT02142738	gptkb:Non-Small_Cell_Lung_Cancer
gptkb:ALTTO_trial	HER2-positive early breast cancer
gptkb:CORIVRON_4	gptkb:COVID-19
gptkb:SURMOUNT-2	obesity
gptkb:MOMENTUM_3_trial	advanced heart failure
gptkb:Adaptive_COVID-19_Treatment_Trial_1	gptkb:COVID-19
gptkb:NeuroPace_Pivotal_Trial	medically refractory partial onset epilepsy
gptkb:CLARITY-AD	gptkb:Alzheimer's_disease
gptkb:ROCKET_trial	gptkb:atrial_fibrillation
gptkb:EPOC16_(SIBO)	Small Intestinal Bacterial Overgrowth
gptkb:PARTNER_3_trial	severe aortic stenosis
gptkb:NCT05240898	gptkb:Alzheimer_Disease
gptkb:MINDACT_trial	gptkb:cancer
gptkb:Relating_Clinical_Outcomes_in_Multiple_Myeloma_to_Personal_Assessment_of_Genetic_Profile_Study	multiple myeloma
gptkb:S0777_(multiple_myeloma_trial)	multiple myeloma
gptkb:Rivaroxaban_Once_Daily_Oral_Direct_Factor_Xa_Inhibition_Compared_with_Vitamin_K_Antagonism_for_Prevention_of_Stroke_and_Embolism_Trial_in_Atrial_Fibrillation	gptkb:atrial_fibrillation
gptkb:TRANSCEND_trial	high-risk patients intolerant to ACE inhibitors